At Pfizer, our purpose is to bring innovative medicines and vaccines to patients to significantly improve their lives. To ensure we are in the best position to fulfill this commitment, we constantly evaluate how we conduct our commercial enterprise to maximize value for our shareholders.
Remaining One Company to Maximize Our Patient Impact
After an extensive evaluation in 2016, we decided to continue the operation of Pfizer Essential Health (PEH) and Pfizer Innovative Health (PIH) as two distinct businesses within Pfizer. We believe this is the best structure to deliver on our purpose and drive value for our shareholders at this time. Having two independent businesses under the Pfizer umbrella allows us to better respond to constantly shifting market dynamics and the distinct requirements of each business’ portfolio, while also simplifying our organizational structure and allowing the company to best serve patient needs.
Pfizer Essential Health
Pfizer Essential Health – formerly known as the Global Established Pharma business – is a leader in non-viral anti-infectives, biosimilars and sterile injectable medicines.
Pfizer Innovative Health
Pfizer Innovative Health includes six business groups – Consumer Healthcare, Inflammation & Immunology, Internal Medicine (neuroscience and pain, and cardiovascular and metabolic), Oncology, Rare Disease and Vaccines.